Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Explore strategies to prevent wasting your credit card benefits and maximize your rewards potential.
14,940 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
NVIDIA leads AI chips while MICRON powers AI memory. This in-depth comparison helps investors decide the better buy: ...
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
IVV and SPY both track the S&P 500, but they aren’t identical. This guide breaks down cost, liquidity, tax considerat...
A new study shows CFOs report productivity boosts from AI, but revenue gains lag behind, hinting at a one-year delay ...
Inflation can erode returns, but there are smarter ways to shield your portfolio. This guide shows two durable energy...
As AI headlines drive swings in tech stocks, investors ask whether Vanguard's broad tech ETF is the right pick for 20...
Macy’s just rolled out an AI-powered shopping assistant across its online and app platforms. Early data show engaged ...
Base, the Coinbase-backed Ethereum Layer 2, is shifting from optimistic rollups to a zero-knowledge-based finality sy...
Lineage (Line) 2026 earnings analysis dives into Q1 results, margin trends, and management’s guidance. Learn what the...
IGIC's Q1 2026 results highlight growth momentum alongside margin pressure. This article breaks down the igic 2026 ea...
Weeks after elon musk called anthropic, SpaceX lands a $4 billion data center deal with Anthropic, signaling a shift ...